The International Transplant-Skin Cancer Collaborative (ITSCC)
www.itscc.org

The International Transplant-Skin Cancer Collaborative (ITSCC) was founded in 2001 by a core group of dermatologic surgeons from several institutions in response to the need to find ways to better manage skin cancers in patients who had received solid organ transplants. ITSCC was an outgrowth of a research project at Mayo Clinic that focused on metastatic skin cancer in transplant patients. As part of the multicenter collaboration for the project, it became evident that many physicians were facing challenges treating skin cancers in organ transplant recipients. An early collaborative group, under the name The North American Transplant Skin Cancer Collaborative, formed which was dedicated to finding optimal care for the skin and skin cancer of these patients. As membership became more diverse, including physicians and researchers from Central and South America, Australia, and other regions, the name was changed to ITSCC to reflect its wider membership. Today, ITSCC is a dynamic, growing collaborative of clinicians and researchers from multiple disciplines dedicated to advancing the care and understanding of skin cancer in organ transplant recipients.